Enveda Announces 1st AI-Discovered Drug Candidate in Clinical Trial
13 Nov 2024 //
BUSINESSWIRE
Enveda Biosciences Hires CMO To Advance Clinical Pipeline
01 Aug 2024 //
BUSINESSWIRE
Enveda Raises $55M To Advance Candidates To Clinical Trials
14 Jun 2024 //
BUSINESSWIRE
Enveda Unveils Chemistry AI Model With Microsoft Collaboration
29 May 2024 //
BUSINESSWIRE
As the market has turned`: Enveda secures $68M to move revised pipeline
21 Dec 2022 //
ENDPTS
Enveda appoints industry leader Mark Deeg as Chief Medical Officer
25 Oct 2022 //
BUSINESSWIRE
Enveda Appoints Pharma Veteran Vanitha Sekar as Chief Business Officer
14 Jul 2022 //
BUSINESSWIRE
Enveda Biosciences Appoints CPO to Support Company’s Rapid Progress
21 Apr 2022 //
BUSINESSWIRE
Enveda Biosciences to Open Advanced Drug Discovery and Development Centers
07 Apr 2022 //
BUSINESSWIRE
Enveda Biosciences Hires New Chief Platform Officer
18 Oct 2021 //
BUSINESSWIRE
Enveda Biosciences Boosts its Translational Capabilities with Two Key Hires
16 Aug 2021 //
BUSINESSWIRE
A Recursion veteran is mapping plant life to chart a course to new therapies
23 Jun 2021 //
ENDPTS
Enveda Biosciences Closes $51M Series A Financing Led by Lux Capital
22 Jun 2021 //
BUSINESSWIRE
Enveda Biosciences Recruits Former Lilly Chief Science Officer as New CSO
21 Apr 2021 //
BUSINESSWIRE